Long-circulating immunoliposome targeting in animal models

Journal of Liposome Research

Volumn 7, Issue 4, 1997, Pages 363-389

  Maruyama, Kazuo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOLIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; PHOSPHATIDYLETHANOLAMINE;

ANIMAL MODEL; ANTIGEN BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG TARGETING; DRUG TRANSPORT; LUNG ENDOTHELIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

EID: 0031445582     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109709035508     Document Type: Review

References (46)

1. Ehrlich P.A. 1956. General review of the recent work in immunity. In "Immunology and cancer research." F. Himmelweit (Ed.). Pergamon Press, London.
2. Poste G., Kirsh R. 1983. Site-specific (targeted) drug delivery in cancer therapy. Biotechnology 1:869-878
3. Gupta P.K. 1990. Drug targeting in cancer chemotherapy: a clinical perspective. J. Pharm. Sci. 79: 949-962
4. Rowlinson-Busza G., Epenetos A.A. 1992. Targeted delivery of biologic and other antineoplastic agents. Curr. Opin. Oncol. 4: 1142-1148
5. Cummings J, Smyth J.F. 1993. Cytotoxic drug delivery. In: "Topics in pharmacy, Vol. III." A.T. Florence and E.G. Salole (Eds.) Butterworth-Heinemann, Oxford, p. 27-53.
6. Wright S. and Huang L. 1989. Antibody-directed liposomes as drug delivery vehicles. Advanced Drug Delivery Reviews. 3: 343-389.
7. Aragnol D. and Leserman L.D. 1986. Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo. Proc. Natl. Acad. Set. USA 83: 2699-2703.
8. Derksen J.T.P., Morselt H.W.M. andScherphof G.L. 1988. Uptake and processing of immunoglobulin-coated liposomes by subpopulation of rat liver macrophages. Biochim. Biophys. Acta 971: 127-136.
9. Peeters, P.A.M., Storm G. and Crommelin D.J.A. 1987. Liposomes in vivo: state of the art. Advanced Drug Delivery Review. 1: 249-266.
10. Maruyama K., Holmberg E., Kennel S., Klibanov A., Torchilin V.P. and Huang L. 1990. Characterization of in vivo immunoliposomes targeting to pulmonary endothelium. J. Pharm. Sci. 79: 978-984.
11. Allen T.M. and Chonn A. 1987. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223: 42-46
12. Klibanov, A., Maruyama, K., Torchilin V.P. and Huang, L. 1990. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268: 235-237.
13. Blume, G. and Cevc, G. 1990. Liposomes for sustained drug release in vivo. Biochim. Biophys. Acta 1029: 91-97.
14. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Young, A.Y. 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066: 29-36.
15. Maruyama, K., Yuda, T., Okamoto, S., Kojima, S., Suginaka, A. and Iwatsuru, M. 1992. Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoylphosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128:44-49.
16. Maruyama K., Okuizumi S., Ishida O., Yamauchi H., Kikuchi H. and Iwatsuru M. 1994. Phosphatidyl polyglycerols prolong liposome circulation in vivo. Int. J. Pharm. 111: 103-107.
17. Torchilin V.P., Shtilman M.I., Trubetskoy V.S., Whiteman K. and Milstein A.M. 1994. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim. Biophys. Acta 1195:181-184.
18. Nanba Y., Sakakibara T., Masada M., Ito F., and Oku N. 1990. Glucronate-modified liposomes with prolonged circulation time. Chem. Pharm. Bull. 38:1663-1666.
19. Lasic D. and Martin F. 1995. Stealth Liposomes. CRC Press, Inc. Boca Raton.
20. Gabizon A. and Papahadjopoulos D. 1988. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA. 85: 6949-6953.
21. Unezaki S., Maruyama K., Ishida O., Suginaka A., Hosoda J. and Iwatsuru M. 1995. Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic polyethylene glycol). Int. J. Pharm. 126: 41-48.
22. Unezaki S., Maruyama K., Takahashi N., Koyama M., Yuda T., Suginaka A. and Iwatsuru M. 1994. Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethyleneglycol in combination with local hyperthermia. Pharm. Res. 11:1180-1185.
23. Kennel S.J., Lankfold T., Hughes B. and Hotchkiss J.A. 1988. Quantitation of a murine lung endothelial cell protein, PI 12, with a double monoclonal antibody assay. Laboratory Investigation 59:692-701.
24. Holmberg E., Ryan U.S., Kennel S.J. and Huang L. 1989. Antibody mediated liposome targeting to mouse pulmonary artery endothelial cells. Biophys. J. 55: 331a.
25. Maruyama K., Holmberg E., Kennel S.J., Klibanov A., Torchilin V.P. and Huang L. 1990. Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J. Pharm. Sci. 79: 978-984.
26. Scherphof G.L., Spanjer H.H., Dijkstra J., Derksen J.T.P. and Roerdink F.H. 1986. Participation of Kupffer cells and hepatocytes in hepatic uptake and processing of liposomes. In: "Medical Application of liposomes" K. Yagi(Ed) Japan Scientific Society Press. New York, p.43-54.
27. Maruyama K., Kennel S.J. and Huang L. 1990. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc. Natl. Acad. Sci. USA. 87: 5744-5748.
28. Allen T.M., Williamson P. and Schlegel R.A. 1988. Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc. Natl. Acad. Sci. USA. 85: 8067-8071.
29. Klibanov A., Maruyama K., Beckerleg A., Torchilin V.P. and Huang L. 1991. Activity of amphipathic polyethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062: 142-148.
30. Mori A., Klibanov A., Torchilin V.P. and Huang L. 1991. Influence of the steric barrier activity of amphipathic poly(ethylene glycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Let. 284:263-266.
31. Maruyama K., Takizawa T., Yuda T., Kennel S.J., Huang L. and Iwatsuru, M. 1995. Targetability of novel immunoliposomes modified with amphipathic polyethyleneglycols conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta. 1234: 74-80.
32. Klibanov A. and Huang L. 1992. Long-circulating liposomes: Development and perspectives. J. Liposome Res. 2:321-334.
33. Jain R.K. and Gerlowski L.E. 1986. Extravascular transport in normal and tumor tissue. Crit. Rev. Oncol. Hematol. 5: 115-170.
34. Dvorak H.F., Nagy J.A., Dvorak J.T. 1988. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133: 95-109.
35. MaedaH. 1992. The tumor blood vessel as an ideal target for macromolecular anticancer agents. J. Control Release 19:315-324.
36. Maeda H., Seymour L.W. and Miyamoto Y. 1992. Conjugation of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjug. Chem. 3: 351-362.
37. Unezaki S., Maruyama K., Hosoda J. Nagae L, Koyanagi Y., Nakata M., Ishida O., Iwatsuru M. and Tsuchiya S. 1996. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int. J. Pharm. 144:11-17.
38. Huang S.K., Lee K.D., Hong K., Friend D.S. and Papahadjopoulos D. 1992. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res. 52: 5135-5143.
39. Uyama I., Kumai K., Yasuda T., Tagawa T., Ishibiki K., Kitajima M. and Tadakuma, T. 1994. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn. J. Cancer Res. 85: 434-440.
40. Ishikawa E., Imagawa H., Hashida S., Yashitake S., Hamaguchi Y. and UenoT. 1983. Enzyme labeling antibodies and their fragments for enzyme immunoassay and immunphistochemical staining. J. Immunoassay 4: 209-327.
41. Maruyama K., Takahashi N., Tagawa T., Nagaike K. and Iwatsuru M. 1997. Immunoliposomes bearing polyethyleneglycol -coupled Fab' fragment show prolonged circulation time and high extravasation into target solid tumors in vivo. FEBS Lett, in press.
42. Maruyama K., Takizawa T., Takahashi N., Tagawa T., Nagaike K. and Iwatsuru M. 1997. Targeting efficiency of PEG-irnmunoliposomeconjugated antibodies at PEG terminals. Advanced Drug Delivery Reviews. 24: 235-242.
43. Ahmad I. and Allen T.M. 1992. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res. 52:4128-4820.
44. Ahmad L, Longenecker M., Samuel J. and Allen T.M. 1993. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53. 1484-1488.
45. Blume G., Cevc G., Crommelin M., Bakker-Woudenberg L, Kluft C. and Storm G. 1993. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta. 1149: 180-184.
46. Lee R.J. and Low P.S. 1994. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269: 3198-3204